RECRUITING

Physical Activity and Nutrition to Halt Elevated Risk in the Pancreas Interception Center

Talk to us

Conditions

Pancreatic Ductal AdenocarcinomaIntraductal Papillary Mucinous NeoplasmPancreatic Cancer

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this Study is to assist in implementing a practical, easy-to-adopt lifestyle intervention that optimizes patient outcomes and minimizes pancreatic ductal adenocarcinoma (PDAC) risk.

Official Title

Physical Activity and Nutrition to Halt Elevated Risk in the Pancreas Interception Center (PANTHER-PIC)

Quick Facts

Study Start:2024-11-13
Study Completion:2027-11
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06712797

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age 18 years or older
  2. * Endoscopically, radiologically, or biopsy-proven pancreatic intraductal papillary mucinous neoplasm (IPMN) over 15 mm in size
  3. * Eastern Cooperative Oncology Group (ECOG) performance status 0-2
  4. * Ability to sign informed consent
  5. * Ability to read and speak English or Spanish
  6. * Body Mass Index (BMI) greater than or equal to 25 kg/m2
  7. * Visceral obesity based on MRI quantification of visceral and subcutaneous fat; ratio of visceral to subcutaneous fat area greater than 0.4 and/or elevated cytokine, incretin or adipokine biomarkers
  1. * No diagnosis of an IPMN
  2. * IPMN with high grade dysplasia, cancer or other high-risk features
  3. * Screen failure for exercise safety
  4. * Underlying unstable cardiac or pulmonary disease or symptomatic cardiac disease
  5. * Recent fracture or acute musculoskeletal injury
  6. * Numeric pain rating scale of 7 or more out of 10
  7. * Myopathic or rheumatologic disease that impacts physical function

Contacts and Locations

Study Contact

Jennifer Permuth, PhD
CONTACT
813-745-5744
Jenny.Permuth@moffitt.org

Principal Investigator

Shaffer Mok, MD
PRINCIPAL_INVESTIGATOR
Moffitt Cancer Center

Study Locations (Sites)

Moffitt Cancer Center
Tampa, Florida, 33612
United States

Collaborators and Investigators

Sponsor: H. Lee Moffitt Cancer Center and Research Institute

  • Shaffer Mok, MD, PRINCIPAL_INVESTIGATOR, Moffitt Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-11-13
Study Completion Date2027-11

Study Record Updates

Study Start Date2024-11-13
Study Completion Date2027-11

Terms related to this study

Keywords Provided by Researchers

  • Pancreatic Ductal Adenocarcinoma
  • Intraductal Papillary Mucinous Neoplasm
  • Pancreatic Cancer

Additional Relevant MeSH Terms

  • Pancreatic Ductal Adenocarcinoma
  • Intraductal Papillary Mucinous Neoplasm